MPMichael L. Piacentino

Michael L. Piacentino

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael L. Piacentino has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    FluoMALDI Imaging: An Integrated Multimodality Platform for Biologically Informed Spatial-Omics

    by Tae-Hun Hahm, Michael L. Piacentino, Waqar Ahmed, Maxime A. Siegler, Dalton R. Brown, Caitlin M. Tressler, Juan C. Troncoso, Arvind P. Pathak, Swati Tanwar, Ishan Barman, et al.

    FluoMALDI imaging integrates fluorescence microscopy and matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) of tissues and cells, leveraging matrix-enhanced fluorescence signals to enable spatially guided functional molecular discovery. Here we report three broadly applicable FluoMALDI paradigms that link how genes, proteins, and organelles shape spatial molecular composition. These advances are achieved by integrating immuno-, HaloTag-, and dye-based labels into a unified FluoMALDI imaging framework. These approaches enabled us to interrogate cell-specific lipidomic compositions in human hippocampal vasculature, neural crest cells in chick embryo tissue, and human induced pluripotent stem cell-derived astrocytes. We also determined that fluorophore-MALDI matrix co-crystals resulted in FluoMALDI-induced fluorescence enhancements. Single-crystal X-ray crystallography showed that their co-crystallization produced localized, finite π-π interactions between two fluorophore molecules, or a fluorophore and a matrix molecule, throughout the crystal lattice. Together, these findings provide structural insight into the basis of fluorescence enhancement and support FluoMALDI as a broadly applicable multimodality imaging platform for biologically informed, cell-specific spatial-omics.

  • Open Access

    New cerebellar nuclei evolve through diversification of excitatory progenitors

    by Manjari M-G Anant, Eli Clemens Zuercher, Maggie Lowman, Caleb Shi, Dylan Z. Faltine-Gonzalez, Michael L. Piacentino, Jean Fan, Justus M. Kebschull

    New brain regions have been proposed to evolve via the duplication of an existing region’s complete set of cell types. Here we investigate the mechanism underlying such apparent evolutionary duplications in the cerebellar nuclei, the output regions of the cerebellum. Using developmental single-cell and spatial transcriptomics time courses in mouse and chicken, we show that formation of new nuclei is governed by changes to nucleus-specific excitatory progenitors. During development, excitatory neurons transcriptomically and spatially define cerebellar nuclei territories, with nucleus- and species-invariant inhibitory neurons incorporating into these territories only after they are established. Across species, evolutionarily conserved excitatory neuron progenitors can generate new nuclei by co-opting border formation gene programs to spatially sort their descendant neurons into distinct territories. While most new nuclei share a common developmental origin and the canonical olivocerebellar error-prediction circuitry, we find the higher order subnuclei of the ancient medial nucleus have a distinct origin and do not participate in the canonical circuit, suggesting a unique evolutionary innovation. Together, our findings suggest that new brain regions can evolve when conserved excitatory cell types first diversify and then spatially segregate, while generic inhibitory neurons are incorporated after regions have formed.

  • Open Access

    The lipid raft-linker gene Raftlin-2 is expressed in migrating neural crest cells

    by Mallorie P. Jenne, Ilya Grabylnikov, Michael L. Piacentino

  • Open Access

    Membrane lipid metabolism as a regulatory frontier in neural crest biology: Roles for sphingolipids, cholesterol, and lipid rafts

    by Allison E. Mancini, Mallorie P. Jenne, Michael L. Piacentino

    Neural crest cells are multipotent, migratory stem‐like cells essential for vertebrate development that contribute broadly to many tissues including the craniofacial skeleton, peripheral nervous system, and pigment‐producing cells. Their development progresses through phases of induction, specification, delamination, migration, and differentiation. Importantly, advancement through these phases requires detecting and responding to extracellular cues through the plasma membrane. While the gene regulatory networks and the signals that govern neural crest development are well characterized, plasma membrane lipid composition as a regulatory layer controlling these transitions remains underexplored. Despite technical limitations in quantitative lipid measurements from vertebrate embryos, genetic and molecular studies have inferred roles of key lipid metabolites. Here we review how membrane lipid metabolism and composition regulate neural crest behavior, focusing primarily on sphingolipids, cholesterol, and lipid raft domains. We examine how morphogen signaling is modified and organized by lipids, how modulating lipid content alters the biophysical state of the neural crest plasma membrane, and the deleterious effects of dysregulated lipid metabolism in neurocristopathies. Drawing parallels to other developmental and disease contexts, we highlight membrane lipid metabolism as a critical frontier in neural crest biology with broad implications for understanding developmental mechanisms and congenital disorders.

  • Open Access

    The lipid raft-linker gene Raftlin-2 is expressed in migrating neural crest cells

    by Mallorie P. Jenne, Ilya Grabylnikov, Michael L. Piacentino

    Transient plasma membrane domains called lipid rafts have emerged as important regulators of signal transduction. These territories are formed by lipid-lipid and lipid-protein interactions, and these local interactions can be scaffolded by resident lipid raft organizing protein family members. While roles for lipid rafts have been described for multiple signaling pathways in many contexts, their in vivo prevalence and role during embryonic development remains incompletely understood. Here we examined gene expression for the Raftlin family of lipid raft organizing proteins, Raftlin ( RFTN1 ) and Raftlin-2 ( RFTN2 ), over the course of early vertebrate development, with a focus on neural crest cell dynamics. By analyzing transcriptomic data across vertebrate species, we identified conserved patterns of RFTN1 and RFTN2 expression across species, where RFTN1 is broadly expressed at low levels, while RFTN2 is distinctly enriched in neural crest cells. We used fluorescent in situ hybridization to spatially define Raftlin gene expression patterns in the early avian embryo. Our results show that RFTN1 is broadly expressed with periods of enrichment in the developing paraxial mesoderm. In contrast, RFTN2 expression is strongly enriched in neural crest cells, beginning during specification and persisting through migration, with additional expression in both the cranial and intermediate mesoderm. Together, these patterns suggest that Raftlins may play important roles in regulating signaling during development with specific roles in somitogenesis and in neural crest and mesodermal cell migrations.


  • Open Access

    Lipid-mediated reinforcement of FGF/MAPK signaling enables robust otic placode specification

    by Stephanie R Peralta, Natalia Maiorana, Michael L Piacentino

    The formation of cranial placodes requires groups of ectodermal cells to interpret inductive signals in a robust and organized manner, yet how signaling responses are coordinated across a developing field remains incompletely understood. During otic placode specification, fibroblast growth factor (FGF) signaling must overcome intrinsic noise and rising inhibitory feedback to drive collective transcriptional responses, suggesting the existence of reinforcing regulatory events beyond ligand-receptor interactions and gene regulatory networks alone. Here we identify the secreted lipid-binding protein Apolipoprotein D (APOD) as an essential mediator of otic placode specification that links lipid-dependent regulation to FGF/MAPK signaling during early development. We find that APOD is strongly expressed in the forming otic placode, where it is necessary for otic specification and morphogenesis. Loss of APOD attenuates ERK1/2 activation, indicating impaired cellular responsiveness to FGF/MAPK signaling. Notably, FGF signaling induces APOD expression, establishing a positive feedback loop that reinforces signaling at the tissue level. These findings reveal lipid-mediated regulation of cell signaling as a critical mechanism enabling robust interpretation of developmental signals during sensory placode formation. More broadly, our work highlights lipid management as a key organizational principle by which embryonic tissues achieve coordinated responses to morphogenetic cues.


  • SMPD3 expression is spatially regulated in the developing embryo by SOXE factors

    by Michael L. Piacentino, Aria J. Fasse, Alexis Camacho-Avila, Ilya Grabylnikov, Marianne E. Bronner


  • Open Access

    Sphingolipid metabolism is spatially regulated in the developing embryo by SOXE genes

    by Michael L. Piacentino, Aria J. Fasse, Alexis Camacho-Avila, Ilya Grabylnikov, Marianne E. Bronner

    During epithelial-to-mesenchymal transition (EMT), significant rearrangements occur in plasma membrane protein and lipid content that are important for membrane function and acquisition of cell motility. To gain insight into how neural crest cells regulate their lipid content at the transcriptional level during EMT, here we identify critical enhancer sequences that regulate the expression of SMPD3 , a gene responsible for sphingomyelin hydrolysis to produce ceramide, which is necessary for neural crest EMT. We uncovered three enhancer regions within the first intron of the SMPD3 locus that drive reporter expression in distinct spatial and temporal domains, together collectively recapitulating the expression domains of endogenous SMPD3 within the ectodermal lineages. We further dissected one enhancer that is specifically active in the migrating neural crest. By mutating putative transcriptional input sites or knocking down upstream regulators, we find that the SoxE-family transcription factors Sox9 and Sox10 regulate the expression of SMPD3 in migrating neural crest cells. Together these results shed light on how core components of developmental gene regulatory networks interact with metabolic effector genes to control changes in membrane lipid content. Highlights: SMPD3 is expressed in the neural tube, neural crest, and notochord during early development SMPD3 expression is regulated by at least three intronic enhancers Sox10 and its binding sites are required for expression by a migratory neural crest-specific SMPD3 enhancer Sox10 is a positive regulator of endogenous SMPD3 expression during neural crest migration

  • Open Access

    Temporal changes in plasma membrane lipid content induce endocytosis to regulate developmental epithelial-to-mesenchymal transition

    by Michael L. Piacentino, Erica J. Hutchins, Cecelia J. Andrews, Marianne E. Bronner

    Epithelial-to-mesenchymal transition (EMT) is a dramatic change in cellular physiology during development and metastasis, which requires coordination between cell signaling, adhesion, and membrane protrusions. These processes all involve dynamic changes in the plasma membrane; yet, how membrane lipid content regulates membrane function during EMT remains incompletely understood. By screening for differential expression of lipid-modifying genes over the course of EMT in the avian neural crest, we have identified the ceramide-producing enzyme neutral sphingomyelinase 2 (nSMase2) as a critical regulator of a developmental EMT. nSMase2 expression begins at the onset of EMT, and in vivo knockdown experiments demonstrate that nSMase2 is necessary for neural crest migration. We find that nSMase2 promotes Wnt and BMP signaling and is required to activate the mesenchymal gene expression program. Mechanistically, we show that nSMase2-dependent ceramide production is necessary for and sufficient to up-regulate endocytosis and is required for Wnt co-receptor internalization. Finally, inhibition of endocytosis in the neural crest mimics the loss of migration and Wnt signaling observed following nSMase2 knockdown. Our results support a model in which nSMase2 is expressed at the onset of neural crest EMT to produce ceramide and facilitate receptor-mediated endocytosis of Wnt and BMP signaling complexes, thereby activating promigratory gene expression. These results highlight the critical role of plasma membrane lipid metabolism in regulating transcriptional changes during developmental EMT programs.


  • Open Access

    RNA-binding protein Elavl1/HuR is required for maintenance of cranial neural crest specification

    by Erica J Hutchins, Shashank Gandhi, Jose Chacon, Michael Piacentino, Marianne E Bronner

    While neural crest development is known to be transcriptionally controlled via sequential activation of gene regulatory networks (GRNs), recent evidence increasingly implicates a role for post-transcriptional regulation in modulating the output of these regulatory circuits. Using available single-cell RNA-sequencing datasets from avian embryos to identify potential post-transcriptional regulators, we found that Elavl1, which encodes for an RNA-binding protein with roles in transcript stability, was enriched in the premigratory cranial neural crest. Perturbation of Elavl1 resulted in premature neural crest delamination from the neural tube as well as significant reduction in transcripts associated with the neural crest specification GRN, phenotypes that are also observed with downregulation of the canonical Wnt inhibitor Draxin. That Draxin is the primary target for stabilization by Elavl1 during cranial neural crest specification was shown by RNA-sequencing, RNA immunoprecipitation, RNA decay measurement, and proximity ligation assays, further supporting the idea that the downregulation of neural crest specifier expression upon Elavl1 knockdown was largely due to loss of Draxin. Importantly, exogenous Draxin rescued cranial neural crest specification defects observed with Elavl1 knockdown. Thus, Elavl1 plays a critical a role in the maintenance of cranial neural crest specification via Draxin mRNA stabilization. Together, these data highlight an important intersection of post-transcriptional regulation with modulation of the neural crest specification GRN.